These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 19305157)

  • 21. Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma.
    Blough MD; Beauchamp DC; Westgate MR; Kelly JJ; Cairncross JG
    J Neurooncol; 2011 Mar; 102(1):1-7. PubMed ID: 20593219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Chk1 inhibitor SAR-020106 sensitizes human glioblastoma cells to irradiation, to temozolomide, and to decitabine treatment.
    Patties I; Kallendrusch S; Böhme L; Kendzia E; Oppermann H; Gaunitz F; Kortmann RD; Glasow A
    J Exp Clin Cancer Res; 2019 Oct; 38(1):420. PubMed ID: 31639020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beryllium sulfate induces p21 CDKN1A expression and a senescence-like cell cycle arrest in susceptible cancer cell types.
    Gorjala P; Gary RK
    Biometals; 2010 Dec; 23(6):1061-73. PubMed ID: 20549306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Action of SN 28049, a new DNA binding topoisomerase II-directed antitumour drug: comparison with doxorubicin and etoposide.
    Drummond CJ; Finlay GJ; Broome L; Marshall ES; Richardson E; Baguley BC
    Invest New Drugs; 2011 Oct; 29(5):1102-10. PubMed ID: 20567995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arsenite induces premature senescence via p53/p21 pathway as a result of DNA damage in human malignant glioblastoma cells.
    Ninomiya Y; Cui X; Yasuda T; Wang B; Yu D; Sekine-Suzuki E; Nenoi M
    BMB Rep; 2014 Oct; 47(10):575-80. PubMed ID: 24499675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA damage causes TP53-dependent coupling of self-renewal and senescence pathways in embryonal carcinoma cells.
    Jackson TR; Salmina K; Huna A; Inashkina I; Jankevics E; Riekstina U; Kalnina Z; Ivanov A; Townsend PA; Cragg MS; Erenpreisa J
    Cell Cycle; 2013 Feb; 12(3):430-41. PubMed ID: 23287532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53.
    Naumann SC; Roos WP; Jöst E; Belohlavek C; Lennerz V; Schmidt CW; Christmann M; Kaina B
    Br J Cancer; 2009 Jan; 100(2):322-33. PubMed ID: 19127257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic effects of temozolomide and radiation are additive- and schedule-dependent.
    Chalmers AJ; Ruff EM; Martindale C; Lovegrove N; Short SC
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1511-9. PubMed ID: 19931733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells.
    Bajbouj K; Mawrin C; Hartig R; Schulze-Luehrmann J; Wilisch-Neumann A; Roessner A; Schneider-Stock R
    J Neurooncol; 2012 May; 107(3):503-16. PubMed ID: 22270849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Dosimetry of Temozolomide: Quantification of Critical Lesions, Correlation to Cell Death Responses, and Threshold Doses.
    Stratenwerth B; Geisen SM; He Y; Beltzig L; Sturla SJ; Kaina B
    Mol Cancer Ther; 2021 Oct; 20(10):1789-1799. PubMed ID: 34253592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines.
    Rubner Y; Muth C; Strnad A; Derer A; Sieber R; Buslei R; Frey B; Fietkau R; Gaipl US
    Radiat Oncol; 2014 Mar; 9(1):89. PubMed ID: 24678590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The combined effect of neutron irradiation and temozolomide on glioblastoma cell lines with different MGMT and P53 status.
    Kinashi Y; Ikawa T; Takahashi S
    Appl Radiat Isot; 2020 Sep; 163():109204. PubMed ID: 32561044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of cell cycle checkpoints and p53 function on the toxicity of temozolomide in human pancreatic cancer cells.
    Gupta S; Sathishkumar S; Ahmed MM
    Pancreatology; 2010; 10(5):565-79. PubMed ID: 20980775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NETRIN-4 protects glioblastoma cells FROM temozolomide induced senescence.
    Li L; Hu Y; Ylivinkka I; Li H; Chen P; Keski-Oja J; Hyytiäinen M
    PLoS One; 2013; 8(11):e80363. PubMed ID: 24265816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone H2AX phosphorylation after cell irradiation with UV-B: relationship to cell cycle phase and induction of apoptosis.
    Halicka HD; Huang X; Traganos F; King MA; Dai W; Darzynkiewicz Z
    Cell Cycle; 2005 Feb; 4(2):339-45. PubMed ID: 15655354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reexpression of hSNF5 in malignant rhabdoid tumor cell lines causes cell cycle arrest through a p21(CIP1/WAF1)-dependent mechanism.
    Kuwahara Y; Charboneau A; Knudsen ES; Weissman BE
    Cancer Res; 2010 Mar; 70(5):1854-65. PubMed ID: 20179200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal embryonic leucine zipper kinase (MELK) reduces replication stress in glioblastoma cells.
    Kig C; Beullens M; Beke L; Van Eynde A; Linders JT; Brehmer D; Bollen M
    J Biol Chem; 2013 Aug; 288(33):24200-12. PubMed ID: 23836907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxaliplatin-induced gamma-H2AX activation via both p53-dependent and -independent pathways but is not associated with cell cycle arrest in human colorectal cancer cells.
    Chiu SJ; Lee YJ; Hsu TS; Chen WS
    Chem Biol Interact; 2009 Dec; 182(2-3):173-82. PubMed ID: 19735649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic inhibition of ATM kinase provides a strategy for glioblastoma multiforme radiosensitization and growth control.
    Golding SE; Rosenberg E; Adams BR; Wignarajah S; Beckta JM; O'Connor MJ; Valerie K
    Cell Cycle; 2012 Mar; 11(6):1167-73. PubMed ID: 22370485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of the glioblastoma cell cycle by type I IFNs occurs at both the G1 and S phases and correlates with the upregulation of p21(WAF1/CIP1).
    Tanabe T; Kominsky SL; Subramaniam PS; Johnson HM; Torres BA
    J Neurooncol; 2000 Jul; 48(3):225-32. PubMed ID: 11100820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.